Parul M. Patel

FDA investigator

Appears on 3 documents from 2014 to 2018, mostly at sites in India. Most often cites general requirements (21 CFR 211.160).

3
Documents on file
4.0
Observations per 483
2014
First seen
2018
Most recent

What they cite most

From 12 observations

Activity by year

2014: 1, 2015: 1, 2018: 1

Where

India 2 · China 1

Is Parul M. Patel coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Sun Pharmaceutical Industries Ltd. Halol - Baroda HighwayFeb 23, 2018 · Halol, India
483 Hisun Pfizer Pharmaceuticals Co., LtdApr 24, 2015 · Fuyang, China
483 Ipca Laboratories LimitedDec 19, 2014 · Piparia, India

About this profile

What does Parul M. Patel inspect?

Parul M. Patel appears on 3 documents on file covering 3 sites, mostly in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.194 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Parul M. Patel is dated Feb 23, 2018.